TGM2 and neoplasm: Factors including gender (male or female), age (≥45 years or <45 years), tumor size, tumor type (unifocality or multifocality), extra-thyroidal extension, AJCC T stage, N stage, pstim-Tg2/pstim-Tg1 (≥0.544 or <0.544), sTg2/sTg1 (≥0.972 or <0.972) and BRAFV600E mutation, were analyzed using the univariate and multivariate logistic regression.